top of page

Timeline of Biotech IPO Filings in Hong Kong
Filing Date
05/07/2018 - Ascletis Pharma
Focus: Antivirals for HCV, HIV and HBV

HK: 1672
06/06/2018 - Hua Medicine
Focus: Type 2 Diabetes

HK: 2552
06/28/2018 - MicuRx Pharmaceuticals
Focus: Antibiotics for superbug infections

06/28/2018 - Innovent Biologics
Focus: Various
HK: 1801

07/03/2018 - AOBiome Therapeutics
Focus: Ammonia-oxidizing bacteria

07/17/2018 - CanSino Biologics
Focus: Vaccines
HK: 6185

07/23/2018 - Viva Biotech Holdings
Focus: CRO

HK: 1873
07/27/2018 - BeiGene
Focus: Oncology
HK: 6160

08/06/2018 - Shanghai Junshi Biosciences
Focus: Oncology, various others

08/20/2018 - Ascentage Pharma
Focus: Oncology, hep B, AMD

08/22/2018 - Mabpharm
Focus: Oncology, autoimmune diseases

09/06/2018 - Hansoh Pharmaceutical Group
Focus: Oncology, CNS, diabetes

HK: 3692
HK: 2359
09/18/2018 - WuXi AppTec
Focus: CRO

10/30/2018 - Liaoning Chenga Biotechnology
Focus: Vaccines

11/13/2018 - CStone Pharmaceuticals
Focus: Oncology

HK: 2616
12/14/2018 - Shanghai Henlius Biotech
Focus: Biologics

HK: 2696
03/11/2019 - Frontage Holdings
Focus: CRO
HK: 1521

04/15/2019 - Hutchison China MediTech
Focus: Oncology

HK: 13
04/18/2019 - Continent Pharmaceuticals
Focus: Fibrosis
04/29/2019 - TOT BIOPHARM
Focus: Oncology
HK: 1875

06/24/2019 - Tasly Biopharma
Focus: Multiple

07/08/2019 - SinoMab BioScience
Focus: Immunology
HK: 3681

07/15/2019 - Alphamab Oncology
Focus: Oncology

08/26/2019 - Pharmaron Beijing
Focus: CRO

09/02/2019 - Immunotech Biopharm
Focus: Cellular Immunotherapy

10/17/2019 - InnoCare Pharma
Focus: Oncology

12/3/2019 - Akeso Biopharma
Focus: Oncology

12/31/2019 - Kintor Pharmaceuticals
Focus: Oncology, various

1/23/2019 - Hepalink Pharmaceutical
Focus: Heparin, various

4/23/2020 - Hangzhou Tigermed Consulting
Focus: CRO

4/29/2020 - Ocumension Therapeutics
Focus: Opthamalogy

6/10/2020 - Simcere Pharmaceutical
Focus: Various

6/29/2020 - RemeGen

Focus: Various
6/30/2020 - Genor Biopharma
Focus: Oncology and Autoimmune

7/19/2020 - Everest Medicines
Focus: Various
HK: 1952

8/14/2020 - JW Therapeutics
Focus: CAR-T

8/18/2020 - Harbour BioMed
Focus: Immunology & Oncology

8/24/2020 - Bio-Thera Solutions
Focus: Biosimilars

8/26/2020 - Antengene
Focus: Oncology

9/08/2020 - SciClone Pharma

Focus: Various
9/17/2020 - Basecare Medical
Focus: Genetic Testing

9/30/2020 - Jacobio Pharma
Focus: Oncology
HK: 1167

11/12/2020 - New Horizon Health
Focus: Cancer Screening

12/18/2020 - Zhaoke Ophthalmology
Focus: Ophthalmology

2/8/2021 - Betta Pharmaceuticals
Focus: Various

2/23/2021 - Kindstar Globalgene Technology
Focus: Diagnostics

2/24/2021 - Apollomics
Focus: Oncology

2/26/2021 - CARsgen Therapeutics
Focus: Cell Therapy

3/08/2021 - YishengBio
Focus: Vaccines

4/01/2021 - Transcenta
Focus: Cancer, Bone, and Kidney

4/08/2021 - Brii Biosciences
Focus: Infectious Disease

4/08/2021 - Keymed Biosciences
Focus: Cancer, Autoimmune

4/23/2021 - Clover Biopharmaceuticals
Focus: COVID19, Oncology, others

4/26/2021 - Advaccine
Focus: Vaccines

4/28/2021 - Lepu Biopharma

Focus: Oncology
5/16/2021 - Novotech Health Holdings
Focus: CRO

6/11/2021 - Bioer Technology
Focus: PCR Testing

6/16/2021 - Abbisko Therapeutics
Focus: Oncology

6/25/2021 - Ambio Pharmaceuticals
Focus: CDMO

6/28/2021 - Asymchem Laboratories
Focus: CDMO

6/29/2021 - ArkBio
Focus: RSV / Anti-fibrosis

6/30/2021 - CanBridge Pharma
Focus: Rare Diseases

6/30/2021 - 3D Medicines
Focus: Immuno-Oncology

6/30/2021 - AIM Vaccines
Focus: Vaccines

7/15/2021 - Siranomics
Focus: RNAi

7/16/2021 - Recbio Technologies
Focus: Vaccines

7/19/2021 - Mabworks
Focus: Oncology and Autoimmune

7/20/2021 - Adlai Nortye

Focus: Oncology
7/29/2021 - IMEiK Technologies
Focus: Medical Aesthetics

8/16/2021 - Mega Genomics
Focus: Genomics Testing

8/25/2021 - TransThera Sciences
Focus: Oncology and Autoimmune

8/29/2021 - Biocytogen
Focus: Oncology

Who Am I?

I'm an individual investor from Kansas City. My focus is on biotech stocks, but I enjoy investing in all industries. I'm an old-school, buy and hold investor who believes the best way to outperform and grow capital is to own innovative companies with good management teams over the long-term. more>>>
More on the web
Follow Me
Resources
HK: 2181
HK: 6855
HK: 3759
HK: 9966
HK: 9969
HK: 9926
HK: 9939
HK: 6978
HK: 1477
HK: 3347
HK: 9989
HK: 2126
HK: 6998
HK: 9995
HK: 6996
HK: 2096
HK: 2142
HK: 6600
HK: 2162
HK: 2137
HK: 2170
HK: 6606
HK: 6622
HK: 2171
bottom of page